Erik Hafkey

Erik Hafkey is the Chief Commercial Officer for Remidio Innovative Solution, a global eye care company with offices in India, Singapore and the US.  Remidio’s specialty is developing devices that expand the reach of eye care into remote, underserved and rural areas of the world through mobility, connectivity, and AI.  They lead the world with on-the-edge AI for diabetic retinopathy, glaucoma, age-related macular degeneration and more. Remidio products have saved sight in more than 7.5 million people worldwide.

Mr. Hafkey’s role is to oversee the commercialization strategies for the Remidio brands and manage all North America operations.  He oversees all US system integrations and is the lead for Remidio’s diabetic retinopathy screen programs with corporate partners and teaching institutions.  And he drives business development projects in the US and LATAM.

Prior to Remidio, Mr. Hafkey was SVP for US operations for ifa united i-tech, an ophthalmic specific EMR company based in Germany.  He was a member of the AAO IHE committee, spearheading marketing effort to gain vendor adoption of standard data structure to improve interoperability.  He also has many years of successful sales and brand management experience with Allergan.